thymidine has been researched along with suramin in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (34.21) | 18.7374 |
1990's | 21 (55.26) | 18.2507 |
2000's | 4 (10.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vischer, TL | 1 |
Folkman, J; Grugel, R; Hoppe, J; Marmé, D; Schöllmann, C; Tatje, D; Weich, HA | 1 |
Czernin, S; Dorfinger, K; Grubeck-Loebenstein, B; Niederle, B; Nowotny, P; Peterlik, M; Vierhapper, H; Waldhäusl, W; Wilfing, A | 1 |
Jalink, K; Moolenaar, WH; van Blitterswijk, WJ; van Corven, EJ; van der Bend, RL; van Rijswijk, A | 1 |
Abboud, HE; Dubyak, GR; Hsieh, P; Kenney, W; Knauss, TC; Pierce, GF; Pinzani, M | 1 |
Anderson, CW; Davis, RG; Jindal, HK; Vishwanatha, JK | 1 |
De Clercq, E | 1 |
Hirsch, MS; Schooley, RT; Vogt, M | 1 |
Pomerantz, RJ; Schooley, RT | 1 |
Broder, S; Kuno, S; Looney, DJ; Mitsuya, H; Ueno, R; Wong-Staal, F | 1 |
Brun, R; Kunz, C | 1 |
Kaplan, JC; Sandström, EG | 1 |
Broder, S; Yarchoan, R | 1 |
Sandström, E | 1 |
Weber, J | 1 |
Marwick, C; Riesenberg, DE | 1 |
Barnes, DM | 1 |
Rada, B | 1 |
Molloy, CJ; Taylor, DS; Weber, H | 1 |
Bicknell, R; Braddock, PS; Fan, TP; Harris, AL; Hu, DE; Stratford, IJ | 1 |
Ardizzoni, A; de Cupis, A; Favoni, RE; Noonan, D; Pirani, P; Ravera, F | 1 |
Adams, EF; Bickel, A; Fahlbusch, R; Gauer, S; Hren, J; Kiesewetter, F; Schrell, UM | 1 |
Cooper, M; Linehan, WM; Trahan, EE; Venzon, D; Walther, MM | 1 |
August, EM; Cysyk, RL; Duncan, KL; Malinowski, NM | 1 |
Lauber, B; Mórocz, IA; Schmitter, D; Stahel, RA | 1 |
Ewing, MW; Gnarra, JR; Linehan, WM; Liu, SC; Meyers, CE; Walther, MM | 1 |
Garvin, AJ; Hazen-Martin, DJ; Vincent, TS | 1 |
Culic, O; Lemmens, R; Teuchy, H; Vanduffel, L | 1 |
Frank, H; Hombach, V; Mayr, U; Waltenberger, J | 1 |
Boilly, B; Boilly-Marer, Y; Desbiens, X; Hondermarck, H; Oudghir, M; Zenjari, C | 1 |
Barsouk, A; Campbell, PG; Levitt, ML; Lokshin, A; Peng, X | 1 |
Hinek, A; Jung, S; Rutka, JT | 1 |
Loir, M | 1 |
Abdiu, A; Larsson, SE; Walz, TM; Wasteson, A | 1 |
Brohard-Bohn, B; de Nucci, G; Lafay, M; Marcondes, S; Rendu, F | 1 |
Boarder, MR; Kumari, R; London, NJ; Ng, LL; Porter, KE; White, PJ | 1 |
Neary, JT; Washburn, KB | 1 |
Chowdhury, TT; Knight, MM | 1 |
6 review(s) available for thymidine and suramin
Article | Year |
---|---|
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxylic Acid; Deltaretrovirus; Deoxycytidine; Foscarnet; Genes, Viral; Glycoproteins; Humans; Interferons; Male; Phosphonoacetic Acid; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Suramin; Thymidine; Transcription, Genetic; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine | 1986 |
Therapy of human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Humans; Immunotherapy; Interferons; Oligodeoxyribonucleotides; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Zidovudine | 1987 |
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Antiviral drugs for AIDS. Current status and future prospects.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1986 |
[Experimental chemotherapy of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1988 |
1 trial(s) available for thymidine and suramin
Article | Year |
---|---|
[Chemotherapy and immunoprophylaxis of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Suramin; Thymidine; Viral Vaccines; Virus Replication; Zidovudine | 1986 |
31 other study(ies) available for thymidine and suramin
Article | Year |
---|---|
Suramin stimulates B-lymphocyte proliferation in the mouse.
Topics: Animals; B-Lymphocytes; Cells, Cultured; Fluorescent Antibody Technique; Hydrocortisone; Lymphocyte Activation; Mice; Mice, Nude; Mitosis; Spleen; Stimulation, Chemical; Suramin; Thymidine; Time Factors | 1976 |
Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells.
Topics: Animals; Aorta; Cattle; Cell Division; Cells, Cultured; DNA Replication; Drug Synergism; Fibroblast Growth Factor 2; Heparin; Humans; Kinetics; Macromolecular Substances; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Mas; Receptors, Cell Surface; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Suramin; Thymidine; Transcription, Genetic; Up-Regulation | 1992 |
The effects of suramin on human adrenocortical cells in vitro: suramin inhibits cortisol secretion and adrenocortical cell growth.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Male; Middle Aged; Suramin; Thymidine | 1991 |
Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.
Topics: Animals; Cell Division; Cell Line; DNA Replication; Endothelins; Epidermal Growth Factor; Kinetics; Lysophospholipids; Phosphatidic Acids; Structure-Activity Relationship; Suramin; Thymidine | 1992 |
Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells.
Topics: Animals; Calcium; Cell Division; DNA Replication; Inositol; Inositol Phosphates; Kinetics; Liver; Macromolecular Substances; Male; Mitogens; Platelet-Derived Growth Factor; Rats; Rats, Inbred Strains; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship; Suramin; Thymidine | 1991 |
Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.
Topics: DNA Polymerase II; DNA Replication; DNA, Neoplasm; DNA, Viral; HeLa Cells; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Simian virus 40; Suramin; Thymidine | 1990 |
Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.
Topics: Antigens, Differentiation, T-Lymphocyte; Cell Line; Dextran Sulfate; Dextrans; Dideoxynucleosides; DNA, Viral; Fluorescent Antibody Technique; HIV; HIV Envelope Protein gp120; Immunologic Techniques; Retroviridae Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Suramin; T-Lymphocytes, Helper-Inducer; Thymidine; Viral Fusion Proteins; Virion; Zidovudine | 1988 |
In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotes.
Topics: Animals; Arsenicals; Diminazene; Hypoxanthine; Hypoxanthines; Leucine; Pentamidine; Phenanthridines; Suramin; Thymidine; Trypanocidal Agents; Trypanosoma brucei brucei | 1989 |
AIDS: the virus, antivirals and vaccines.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine | 1987 |
Anti-AIDS agents show varying early results in vitro and in vivo.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1985 |
In search of the best drugs against AIDS.
Topics: Acquired Immunodeficiency Syndrome; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Zidovudine | 1986 |
Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Topics: 3T3 Cells; Angiotensin II; Animals; Antibodies; Aorta; Becaplermin; Cell Division; Culture Media, Conditioned; DNA; Dose-Response Relationship, Drug; Genes, fos; Growth Substances; Kinetics; Mice; Mitogens; Muscle, Smooth, Vascular; Phosphoproteins; Phosphotyrosine; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Suramin; Thymidine; Tyrosine | 1994 |
A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.
Topics: Animals; Capillaries; Cattle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Inflammation; Male; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pentosan Sulfuric Polyester; Rats; Rats, Wistar; Structure-Activity Relationship; Suramin; Thymidine | 1994 |
Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
Topics: Adenocarcinoma; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; DNA; Dose-Response Relationship, Drug; Formazans; Humans; Insulin-Like Growth Factor I; Lung Neoplasms; Mitogens; Radioligand Assay; Suramin; Tetrazolium Salts; Thymidine; Tumor Cells, Cultured | 1994 |
Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Topics: Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug; Epidermal Growth Factor; Flow Cytometry; Growth Substances; Humans; Insulin-Like Growth Factor I; Meningioma; Platelet-Derived Growth Factor; Receptors, Growth Factor; Suramin; Thymidine; Tumor Cells, Cultured | 1995 |
Suramin inhibits proliferation and DNA synthesis in transitional carcinoma cell lines.
Topics: Animals; Carcinoma, Transitional Cell; Cell Division; Cell Line; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Suramin; Thymidine; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Inhibition of fibroblast hyaluronic acid production by suramin.
Topics: 3T3 Cells; Animals; Cell Division; Culture Media; DNA; Dose-Response Relationship, Drug; Fibroblasts; Glucuronosyltransferase; Glycosyltransferases; Humans; Hyaluronan Synthases; Hyaluronic Acid; Kinetics; Male; Membrane Proteins; Mice; Prostatic Neoplasms; Suramin; Thymidine; Transferases; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate N-Acetylglucosamine; Xenopus Proteins | 1993 |
In vitro effect of suramin on lung tumour cells.
Topics: DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leucine; Lung Neoplasms; Suramin; Thymidine; Time Factors; Tumor Cells, Cultured | 1993 |
Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.
Topics: Blotting, Northern; Cell Cycle; Cell Division; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms; RNA, Neoplasm; Suramin; Thymidine; Time Factors | 1993 |
Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
Topics: Animals; Antibodies; Antineoplastic Agents; Cell Division; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Insulin-Like Growth Factor II; Kidney Neoplasms; Kinetics; Mice; Mice, Nude; Mitotic Index; Radioligand Assay; Receptor, IGF Type 1; Receptor, IGF Type 2; Suramin; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured; Wilms Tumor | 1996 |
Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: the role of ecto-enzymes.
Topics: 5'-Nucleotidase; Acid Anhydride Hydrolases; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cell Division; Cell Line; Cell Line, Transformed; Dinucleoside Phosphates; Dipyridamole; Enzyme Inhibitors; HeLa Cells; Humans; Levamisole; Nucleoside-Triphosphatase; Nucleosides; Nucleotides; Suramin; Thymidine; Triazines | 1996 |
Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
Topics: Animals; Cell Movement; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Lymphokines; Mitogens; Neovascularization, Physiologic; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Suramin; Swine; Thymidine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |
Experimental evidence for FGF-1 control of blastema cell proliferation during limb regeneration of the amphibian Pleurodeles waltl.
Topics: Animals; Antibodies, Monoclonal; Carrageenan; Cell Division; Extremities; Fibroblast Growth Factors; Fluorescent Antibody Technique; Heparin; Immunotoxins; N-Glycosyl Hydrolases; Pentosan Sulfuric Polyester; Plant Proteins; Pleurodeles; Receptors, Fibroblast Growth Factor; Regeneration; Ribosome Inactivating Proteins, Type 1; Saporins; Suramin; Thymidine | 1996 |
Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Cell Division; Dimerization; DNA, Neoplasm; ErbB Receptors; Humans; Insulin-Like Growth Factor II; Lung Neoplasms; Phosphorylation; Suramin; Thymidine; Tumor Cells, Cultured | 1999 |
Cell surface aggregation of elastin receptor molecules caused by suramin amplified signals leading to proliferation of human glioma cells.
Topics: Cell Division; Culture Media, Serum-Free; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Elastin; Glioma; Humans; Intracellular Fluid; Laminin; Receptors, Cell Surface; Signal Transduction; Suramin; Thymidine; Tritium; Tropoelastin; Tumor Cells, Cultured; Up-Regulation | 1999 |
Spermatogonia of rainbow trout: III. In vitro study of the proliferative response to extracellular ATP and adenosine.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cell Division; Gonadotropins, Pituitary; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Oncorhynchus mykiss; Receptors, Purinergic P1; Receptors, Purinergic P2; Spermatogenesis; Spermatogonia; Suramin; Testis; Thymidine | 1999 |
Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro.
Topics: Antineoplastic Agents; Cell Division; Histiocytoma, Benign Fibrous; Humans; Platelet-Derived Growth Factor; Suramin; Thymidine; Tumor Cells, Cultured | 1999 |
Platelets induce human umbilical vein endothelial cell proliferation through P-selectin.
Topics: Aspirin; Blood Platelets; Cell Adhesion; Cell Division; Cell Line; Endothelium, Vascular; Female; Humans; Ketanserin; Mitogens; P-Selectin; Platelet Aggregation Inhibitors; Pregnancy; Serotonin; Suramin; Thrombin; Thymidine; Umbilical Veins | 2000 |
Antiproliferative effect of UTP on human arterial and venous smooth muscle cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Calcium; Cell Division; Cells, Cultured; Humans; Inositol 1,4,5-Trisphosphate; Mammary Arteries; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Saphenous Vein; Suramin; Thymidine; Tritium; Type C Phospholipases; Uridine Triphosphate | 2000 |
P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Astrocytes; Blotting, Western; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Serine; Signal Transduction; STAT3 Transcription Factor; Suramin; Theophylline; Thymidine; Time Factors; Tritium; Uridine Triphosphate | 2006 |
Purinergic pathway suppresses the release of .NO and stimulates proteoglycan synthesis in chondrocyte/agarose constructs subjected to dynamic compression.
Topics: Adenosine Triphosphate; Animals; Apyrase; Cattle; Cell Proliferation; Cells, Cultured; Chondrocytes; Compressive Strength; Gadolinium; Nitric Oxide; Nitrites; Proteoglycans; Purinergic P2 Receptor Antagonists; Purines; Radioisotopes; Receptors, Purinergic P2; Sepharose; Signal Transduction; Sulfates; Suramin; Thymidine | 2006 |